• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAmbrx Biopharma
    Picture of Ambrx Biopharma logo

    AMAM — Ambrx Biopharma Share News

    $27.980.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapHigh Flyer
    • Market Cap
      $1.76bn
    • Enterprise Value
      $1.54bn
    • Revenue
      $7.40m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • AMAM Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    AMAM Dividends
    • Brief: FDA Grants Fast Track Designation For Ambrx's ARX517

      19/07/2023 14:25
    • Brief: Ambrx Announces Closing Of $75 Million Market Priced Registered Offering

      28/06/2023 13:47
    • U.S. RESEARCH ROUNDUP-Catalent, Estee Lauder Companies, Marqeta

      14/06/2023 07:57
    • U.S. RESEARCH ROUNDUP-Apple, Cabot, Epam Systems

      06/06/2023 08:23
    • Brief: Ambrx Announces $75 Mln Market Priced Registered Offering

      24/05/2023 13:43
    • Brief: Ambrx Appoints Stephen Glover As Chairman Of Its Board Of Directors

      18/05/2023 22:20
    • Brief: Ambrx Biopharma Inc Files For Stock Shelf Of Up To $300 Million - SEC Filing

      30/03/2023 22:44
    • U.S. STOCKS ON THE MOVE-Tesla, Neptune Wellness, Ardelyx

      19/12/2022 13:17
    Previous12Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.